תבנית:תרופה/ארקליסט - Arcalyst

× ×ª×× × ×ª×¨××¤×

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	L04AC Interleukin inhibitors
××¨××× ×¤×¢×× (ATC5)	*Rilonacept 80MG/ML âL04AC04 Rilonacept 80MG/ML âL04AC04 Interleukin inhibitors L04AC âL04AC04 3001 red lion rd.,philadelphia ,pennsylvania 19114, USA packaging , labelling âL04AC04 870 parkdale road, rochester, michigan 48307, USA ID & sterility testing , Filler âL04AC04 81 columbia turnpike rensselaer, new york 12144, USA release of drug product , stabilty testing , formulated drug substance manufacturing site âL04AC04 616 hearthrow drive lincolinshire, il 60069, USA Container closure integrity testing âL04AC04 Rilonacept 80MG/ML âL04AC04
×¦××¨×ª ××ª×	S.C
×¦××¨×ª ××× ××	LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION
××ª××××	Arcalyst (rilonacept) is an interleukin-1 blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in adults and children 12 and older.

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××¨×§×××¡× Â® ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	REGENERON PHARMACEUTICALS, INC., USA
×©× ××¢× ××¨××©××	NEOPHARM (ISRAEL) 1996 LTD
×¨××©×××	×ª××¨×× ×××©×: 10/2016. ×¨××©××× ××ª××¨××: 10/2016
×ª××¨×× ×¢×××× ×××¨××	14/11/18

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/××¨×§×××¡× - Arcalyst}}

×:

{{×ª×¨××¤×/××¨×§×××¡× - Arcalyst
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־14 בנובמבר 2018 ב־15:12

ויקיתרופות